This enhanced fitness among vaccine-induced CD8+ TIL cells after skin immunization was also associated with spreading of the host T cell response to include recognition of melanoma Ags (gp100, TRP1) not included in the vaccine (figure 6), which we did not observe in mice treated with DC-based genetic vaccine. This evidence concerns the gene CD8A and melanoma.